Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07419607

MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducation for Adolescents With Migraine

Background: Migraine is a headache disorder highly prevalent in children and adolescents. It significantly affects academic performance and quality of life. A conservative approach to pharmacological prophylaxis for pediatric patients persists in clinical practice, as potential risks must be carefully weighed against the benefits for each individual patient. Non-pharmacological interventions, including physical activity, progressive muscle relaxation (PMR) and psychoeducation have shown promising effects individually but demand a high level of patient motivation. This study protocol creates the foundation to evaluate a novel group therapy program combining high-intensity interval training (HIIT), PMR, and psychoeducation tailored for children and adolescents with migraine.

Methods: This single-centre, open-label, randomized controlled trial will enrol 80 participants aged 13 to 17 years and diagnosed with migraine according to ICHD-3 criteria. Participants are randomized 1:1 into an intervention and control group. The intervention group will receive a 18-week, once-weekly 65-minute group therapy (comprising HIIT and PMR) plus two sessions of psychoeducation. The control group receives no intervention. Primary outcomes are changes in migraine frequency, duration, intensity and acute medication use, assessed through standardized headache diaries before and after the intervention. Secondary outcomes include changes in migraine-related disability (PedMIDAS questionnaire), exploratory analysis of physical activity patterns in a subgroup and a patient-centered evaluation of the intervention's feasibility and perceived effectiveness.

Discussion: This trial will provide evidence on the effectiveness and feasibility of a structured, time-efficient, multimodal group therapy intervention for pediatric migraine. By combining physical and psychological strategies within a supportive group setting, the program aims to overcome key limitations of adherence and offer a non-pharmacological treatment alternative. If successful, the intervention is intended to be incorporated into routine outpatient care for pediatric migraine at the Medical University of Innsbruck.

Recruiting

Interested in participating?

Request Info

Key information

Age range

13 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Pediatric and Adolescent Medicine

Innsbruck, Tyrol, 6020, Austria

Location status: Recruiting

Location contact

Alina Peternell, MD

SUB_INVESTIGATOR

Christian Lechner, MD

CONTACT

[email protected]

+4351250423531

Christian Lechner, MD

PRINCIPAL_INVESTIGATOR

Kerstin Weissenegger, MD

SUB_INVESTIGATOR

Matthias Baumann, MD

CONTACT

[email protected]

+4351250423531

Matthias Baumann, MD

SUB_INVESTIGATOR

Nick Milobara

SUB_INVESTIGATOR

Niklas Winkelmann

SUB_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed migraine as defined by ICHD-3 (International Classification of Headache Disorders, 3rd edition)
  • Age: 13-17 years
  • Place of residence within a 35-kilometer radius of the study site, except for children who live outside of this radius but commute close to the study site daily due to school or work attendance

Exclusion criteria

  • Intake of continuous prophylactic medication for migraine
  • Any change in migraine medication within the past 4 weeks
  • Psychiatric or somatic comorbidities which could interfere with participation in a weekly group therapy that includes physical activity

Treatment and study plan

Weekly group training

Behavioral

Weekly high-intensity interval training followed by progressive muscle relaxation in a group setting, plus two additional psychoeducation sessions focusing on pain management

Primary outcomes

  1. Mean change from baseline in migraine headache frequency

    Time frame: From enrollment to the end of treatment at 4 weeks

    Mean change from baseline in the number of monthly headache days, defined as any calendar day with headache.

  2. Mean change from baseline in migraine intensity

    Time frame: From enrollment to the end of treatment at 4 weeks

    Mean change from baseline in migraine intensity measured using a 0-10 visual analogue scale (VAS), where 0 indicates no pain and 10 indicates worst imaginable pain.

  3. Mean change from baseline in migraine duration

    Time frame: From enrollment to the end of treatment at 4 weeks

    Mean change from baseline in the duration of migraine, expressed as the number of hours of pain per migraine day.

Secondary outcomes

  1. Degree of migraine-related impairment using the mean change in the PedMIDAS questionnaire´s total score

    Time frame: From enrollment to the end of treatment at 4 weeks

    Migraine-related disability was assessed using the Pediatric Migraine Disability Assessment (PedMIDAS) questionnaire (total score range: 0-276). Higher scores indicate greater migraine-related disability (worse outcome). The outcome parameter was the mean change from baseline in the PedMIDAS total score.

Study contacts

Contact information is provided by the study sponsor or research team.

Christian Lechner, MD

CONTACT

[email protected]

+4351250423531

Sponsors and collaborators

Lead sponsor

Medical University Innsbruck

Other

Registry information

Official study title

MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducation for Adolescents With Migraine - Study Protocol for a Randomized Controlled Trial

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Feb 19, 2026
Registry last updated
Feb 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.